# Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma

> **NCT00375791** · PHASE2 · COMPLETED · sponsor: **AEterna Zentaris** · enrollment: 67 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** perifosine
- **DRUG:** dexamethasone

## Key facts

- **NCT ID:** NCT00375791
- **Lead sponsor:** AEterna Zentaris
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2010-12
- **Final completion:** 2011-10
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2018-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00375791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00375791, "Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00375791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*